Wegovy 1.7mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Wegovy 1.7mg Injection
contains Semaglutide 1.7mg per dose in a once-weekly pre-filled pen. This is the penultimate escalation step before reaching the full 2.4mg maintenance dose. At 1.7mg, the majority of the drug's weight-loss benefit is already being realised, and patients commonly observe accelerated progress in their weight-management goals.
Benefits:
- Near-maximum GLP-1 receptor engagement for advanced appetite control
- Significant weekly caloric deficit driven by reduced hunger and satiety signalling
- Contributes to 15–17% body weight reduction achieved by the maintenance phase
- Improves cardiometabolic risk factors including blood pressure and triglycerides
- Prepares the physiology for the final escalation to the 2.4mg maintenance dose
How It Works:
At 1.7mg, semaglutide achieves near-maximal GLP-1 receptor activation. The drug strongly suppresses appetite and hunger signalling in the CNS, markedly reduces gastric motility, and amplifies glucose-dependent pancreatic responses. Patients at this dose level typically experience pronounced satiety with substantially smaller meal sizes, facilitating a consistent caloric deficit necessary for meaningful and sustained weight loss.
Dosage and Administration:
Inject 1.7mg subcutaneously once weekly after 4 weeks on the 1mg dose. Administer into the abdomen, thigh, or outer upper arm at any time of day. Rotate injection sites. After 4 weeks at 1.7mg, the prescriber will advance to the 2.4mg maintenance dose.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, decreased appetite, abdominal discomfort. Uncommon: increased heart rate, headache, fatigue. Serious: pancreatitis, gallbladder disease, worsening of diabetic retinopathy, acute kidney injury.
Precautions:
Contraindicated in history of medullary thyroid carcinoma or MEN2. Monitor for worsening of pre-existing diabetic retinopathy during rapid HbA1c improvement. Ensure adequate hydration if vomiting or diarrhoea occurs.
Wegovy Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | View → |
| 0.5mg | Standard strength option | 2–4 wks | Weekly | View → |
| 1mg | Popular strength option | 2–4 wks | Weekly | View → |
| 1.7mg | Higher strength option | 2–4 wks | Weekly | Current |
| 2.4mg | Maximum strength variant | 2–4 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Wegovy 1.7mg used for?
Wegovy 1.7mg is the fourth escalation dose in the Wegovy chronic weight management programme, used for 4 weeks before advancing to the 2.4mg maintenance dose. At this level, near-maximal weight-loss benefit is being delivered.
Q2: Why does Wegovy have so many escalation steps?
The five-step escalation (0.25→0.5→1→1.7→2.4mg) is designed to minimise gastrointestinal side effects. Jumping to the maintenance dose immediately would cause intolerable nausea and vomiting in most patients.
Q3: How much more weight do I lose at 1.7mg compared to 1mg?
The difference between 1mg and 1.7mg is incremental. Most of the additional weight-loss benefit of higher doses becomes apparent at the 2.4mg maintenance level. The 1.7mg phase is primarily a stepping stone.
Q4: Can Wegovy 1.7mg cause mood changes?
Some patients on semaglutide report mood changes, increased irritability, or low mood. In rare cases, thoughts of self-harm have been reported. If you notice significant mood changes, contact your prescriber promptly.
Q5: What if I still have nausea at 1.7mg?
Persistent nausea at higher doses can occur. Eating smaller meals, avoiding fatty or spicy foods, not lying down after meals, and eating slowly can help. Your prescriber may consider prolonging the 1mg phase before advancing.
Q6: Can I take anti-nausea medication with Wegovy 1.7mg?
Some anti-nausea medications (e.g., ondansetron) can be used short-term under medical supervision. Discuss with your prescriber before using any anti-emetics, as some may affect GI motility.
Q7: Is there a difference between Wegovy 1.7mg and Ozempic 1mg in clinical effect?
Wegovy 1.7mg delivers approximately 70% more semaglutide per dose than Ozempic 1mg, resulting in greater appetite suppression. However, the effects are qualitatively similar; the Wegovy escalation programme as a whole achieves far greater weight loss than Ozempic.
Q8: Does Wegovy 1.7mg reduce blood pressure?
Yes. As weight loss progresses, systolic blood pressure typically decreases by 3–5 mmHg on semaglutide. Your prescriber may need to adjust antihypertensive medications as your weight decreases.
Q9: Will Wegovy 1.7mg affect my sleep?
Weight loss can significantly improve obstructive sleep apnoea. Some patients report improved sleep quality during Wegovy treatment. However, if you develop new sleep disturbances, mention them to your prescriber.
Q10: How do I know if my dose selector is on 1.7mg?
Each Wegovy pen is pre-set to deliver a single specific dose — the 1.7mg pen only delivers 1.7mg. There is no dose adjustment on a Wegovy pen; each escalation step requires a separate pen.
Customer Reviews
Robert Chen
Canada · 1 month ago
“Very satisfied with the order. Packaging was secure and delivery was on time. Quality matches the description perfectly.”
Dr. Emily Parker
UK · 2 months ago
“Impressed with the professionalism. Certificate of Analysis provided on request. Will be placing repeat orders for our clinic.”
Metro Hospital Pharmacy
UK · 2 weeks ago
“Reliable supplier. Product met all our quality standards. Great communication throughout the entire procurement process.”
Global Meds Supply
Germany · 6 weeks ago
“Ordering from Medionix for several months now. Consistent pharmaceutical quality and professional service every time.”
Thomas B.
Australia · 4 months ago
“Legitimate pharmaceutical supplier. Packaging intact, expiry dates clearly printed, batch numbers traceable. Very satisfied.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.